Strateos

Strateos

Remote lab automation for life sciences

Overview

Strateos provides remote access laboratories and lab control software for life science discovery. It operates an Automation-as-a-Service Platform that lets scientists remotely design, run, and analyze experiments using data, computation, automation, and high-throughput robotics to enable faster, reproducible scientific work. Unlike labs that sell equipment or software alone, Strateos combines remote lab access with integrated automation and analytics so researchers can conduct experiments without being physically present. The company's goal is to advance life sciences by making experiments more efficient, scalable, and data-driven, ultimately accelerating new discoveries.

About Strateos

Simplify's Rating
Why Strateos is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Consulting

Enterprise Software

Cybersecurity

AI & Machine Learning

Company Size

1-10

Company Stage

Acquired

Total Funding

$76.6M

Headquarters

Bordeaux, France

Founded

2019

Simplify Jobs

Simplify's Take

What believers are saying

  • Global lab market growing 24% CAGR; $24B cell assay, gene therapy, synthetic biology TAM.
  • Three revenue streams: Cloud Lab experiments, Cloud OS software, emerging Tissue Technology.
  • Remote access eliminates traditional CRO delays, enabling faster design-make-test-analyze cycles.

What critics are saying

  • Evotec's March 2026 Noramco acquisition threatens Eli Lilly partnership with integrated competitor.
  • Recursion's AI platform achieves 3x faster hit identification, eroding Strateos' robotics advantage.
  • Tissue Technology remains undeveloped since 2021; no commercialization evidence threatens revenue model.

What makes Strateos unique

  • Merged Transcriptic's cloud lab platform with 3Scan's tissue imaging for integrated drug discovery.
  • Closed-loop robotic automation unifies chemistry, biology, and tissue analysis in single workflow.
  • Established partnerships with Eli Lilly, NIH, MIT, DARPA, and Gilead demonstrate pharma traction.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$76.6M

Above

Industry Average

Funded Over

0 Rounds

Company News

Fusacq
Dec 21st, 2023
PROGRAMISTO s'empare de la startup STRATEOS, FUSACQ Buzz

PROGRAMISTO s'empare de la startup STRATEOS

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Strateos right now.

Find jobs on Simplify and start your career today

We update Strateos's jobs every few hours, so check again soon! Browse all jobs →